# MDxHealth SA (MDXH) — capital_raise [announced]
Source: sec.gov · situation sit_b9f273b2499079ef6f8b · public 6088945595209975398 · retrieved 2026-08-19T13:17:02.276Z

## Overview
MDxHealth SA is a medical laboratory services company providing diagnostic testing services.

On August 11, 2026, funds and entities managed by Bleichroeder LP entered into securities purchase agreements with MDxHealth SA to purchase 24,229,074 ordinary shares in a registered direct offering at $0.454 per share, for an aggregate purchase price of approximately $11,008,039. The Funds also entered into a 90-day lock-up agreement restricting sales or transfers of the purchased shares, subject to customary exceptions. Following this transaction, Bleichroeder beneficially owns 31,648,563 shares, representing 33.2% of MDxHealth's outstanding shares.

## Terms
- Counterparty: MDxHealth SA · Consideration: cash · Stake: 33.2% · Price/share: $0.454

## Key dates
- Announced 2026-08-14 · Expiry 2026-11-09

## Timeline
- 2026-08-14 · SCHEDULE 13D (0001171520-26-000229): SCHEDULE 13D - MDxHealth SA — *MDxHealth SA is a medical laboratory services company providing diagnostic testing services.* On August 11, 2026, funds and entities managed by Bleichroeder LP entered into securities purchase agreements with MDxHealth SA to purchase 24,229,074 ordinary shares in a registered direct offering at $0.454 per share, for an aggregate purchase price of approximately $11,008,039. The Funds also entered into a 90-day lock-up agreement restricting sales or transfers of the purchased shares, subject to customary exceptions. Following this transaction, Bleichroeder beneficially owns 31,648,563 shares, representing 33.2% of MDxHealth's outstanding shares.
  https://www.sec.gov/Archives/edgar/data/1872529/0001171520-26-000229.txt

## Citations
- 0001171520-26-000229 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000117152026000229